Hainsworth, Bryan

Hainsworth, Bryan was paid $152K by Medicaid between Jan 2018 and Feb 2024, across 12 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 44% of everything it billed.

33Billing provider infoHAINSWORTH, BRYAN
FARR WEST, UT 84404

33aNPI1487999488assigned 12/01/2012

33bProvider typeMedical Physician Assistant

28Total paid$152K

24GClaims3,830

24DCodes billed12

24AFirst – last monthJan 2018 – Feb 2024

Compared with peers

Next to other Medical Physician Assistant providers in Utah

Rank by total paid#2 of 26

Median peer was paid$15K

This provider vs. median10×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,385	$21K
2019	13	$252.97
2020	1,557	$80K
2021	281	$17K
2022	160	$10K
2023	332	$14K
2024incomplete	102	$8K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	44%	1,049	735	$67K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	43%	468	337	$66K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	12%	605	409	$18K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	66	46	$676.52
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	320	219	$204.47
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	639	295	$131.52
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	101	64	$32.76
J3475	Injection, magnesium sulfate, per 500 mg	<1%	265	177	$16.63
83986		0%	79	63	$0.00
82570		0%	79	63	$0.00
83992		0%	79	63	$0.00
80305		0%	80	64	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.